Oxygenetix launches acne control foundation

Oxygenetix has developed its first treatment foundation, designed for patients with acne. Oxygenating Acne Control Foundation is clinically proven to treat acne whilst concealing the condition.

The product treats and disguises the condition, with the inclusion of encapsulated salicylic acid (2%), which delivers proprietary acne control ingredients through a patented, breathable delivery system. The hero ingredient in all Oxygenetix products is the pro-healing, patent-pending Ceravitae™, a super charged oxygen complex that promotes collagen cell production and connective tissue growth in compromised skin. It releases the active medicine in even doses throughout the day, which is activated by body heat. Oxygenetix is distributed in the UK by Medical Aesthetic Group.Neogen2.jpg